Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiac Biomarkers Market

Cardiac Biomarkers Market Share

Report ID: GMI7121
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Cardiac Biomarkers Market Share

The cardiac biomarkers industry is consolidated, with major players such as Abbott, Roche dominating the market. These companies are focused on continuous product innovation to secure a significant market share. For instance, in 2021, Roche has unveiled a set of five new proposed applications for two pivotal cardiac biomarkers, utilizing the Elecsys technology: the N-terminal pro-brain natriuretic peptide test and high-sensitive cardiac troponin T. These well-established biomarkers have demonstrated their efficacy in aiding the management of cardiovascular diseases and can assist healthcare professionals in the diagnosis of heart attacks and the improved management of heart failure. The introduction of such products can certainly be advantageous for the company
.

Some of the eminent market participants operating in the cardiac biomarkers industry include:

Abbott Diagnostics
Roche Diagnostics
Siemens Healthineers
Beckman Coulter
Bio-Rad Laboratories
Ortho Clinical Diagnostics
Randox Laboratories
Quidel Corporation
Radiometer
Tosoh Corporation
Meso Scale Diagnostics (MSD)
Thermo Fisher Scientific
Luminex Corporation
Trinity Biotech
Biomerieux

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cardiac biomarkers industry was valued at USD 9.4 billion in 2022 and is estimated to account for USD 31.2 billion by 2032.

The troponins segment garnered USD 3 billion revenue size in the year 2022 as the product’s exceptional sensitivity and specificity for cardiac injury make it indispensable in the early detection of myocardial infarction, the monitoring of heart-related disorders, and risk assessment in cardiovascular healthcare.

U.S. market accounted for USD 1.4 billion in 2022 and is predicted to witness substantial growth through 2032, owing to the rising cases of heart diseases in the region.

Abbott Diagnostics, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Randox Laboratories, Quidel Corporation, and Radiometer among others.